gamma-aminobutyric acid has been researched along with Cancer of Oropharnyx in 2 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Starmer, HM | 2 |
| Yang, W | 2 |
| Raval, R | 1 |
| Gourin, CG | 2 |
| Richardson, M | 1 |
| Kumar, R | 2 |
| Jones, B | 2 |
| McNutt, T | 2 |
| Cheng, Z | 1 |
| Cheng, S | 2 |
| Quon, H | 2 |
2 other studies available for gamma-aminobutyric acid and Cancer of Oropharnyx
| Article | Year |
|---|---|
Effect of gabapentin on swallowing during and after chemoradiation for oropharyngeal squamous cell cancer.
Topics: Amines; Analgesics; Carcinoma, Squamous Cell; Chemoradiotherapy; Cyclohexanecarboxylic Acids; Deglut | 2014 |
One-Year Swallowing Outcomes in Patients Treated with Prophylactic Gabapentin During Radiation-Based Treatment for Oropharyngeal Cancer.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Deglutition; Female; Gabapentin; gamma-Aminobutyric | 2017 |